Pepita Yap-adefuin, MD | |
136 Sherman Ave, Ste 405, New Haven, CT 06511-5238 | |
(203) 787-0117 | |
(203) 777-3559 |
Full Name | Pepita Yap-adefuin |
---|---|
Gender | Female |
Speciality | Internal Medicine - Nephrology |
Location | 136 Sherman Ave, New Haven, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1902894181 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | 16198 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Pepita Yap-adefuin, MD 136 Sherman Ave, Ste 405, New Haven, CT 06511-5238 Ph: (203) 787-0117 | Pepita Yap-adefuin, MD 136 Sherman Ave, Ste 405, New Haven, CT 06511-5238 Ph: (203) 787-0117 |
News Archive
The 30-day window for hospital readmissions - used by the federal government to penalize hospitals believed to provide lower-quality care because patients return to the hospital following discharge - should be reduced to a week or less to more accurately measure factors within a hospital's control, new research from UC Davis has found.
Evidence of resistance to the antimalarial drug artemisinin and its derivatives threatens efforts to control malaria in Southeast Asia, and experts fear artemisinin resistance may spread from the Thailand-Cambodia border to affect other malaria endemic countries. Evidence to such effect was presented today at the 58th annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH).
Studies representing nearly 2 million adults worldwide show that eating about five daily servings of fruits and vegetables, in which 2 are fruits and 3 are vegetables, is likely the optimal amount for longer life, according to new research published today in the American Heart Association's flagship journal Circulation.
RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that Tod Woolf, Ph.D., President and CEO, along with members of RXi's management team, will ring the Nasdaq closing bell tomorrow, Tuesday, Oct 6, 2009 at the Nasdaq Marketsite in New York City's Times Square.
The Senate Appropriations Committee on Thursday passed the FY 2013 Labor, Health & Human Services, Education and Related Agencies appropriations bill by 16-14, The Hill's "On the Money" blog reports.
› Verified 9 days ago
Dr. Brian Christopher Cambi, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 333 Cedar St, Dcb 3, New Haven, CT 06510 Phone: 203-785-4129 Fax: 203-737-2437 | |
Ms. Maryam Gondal, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 330 Cedar Street, Bb 114, New Haven, CT 06510 Phone: 203-785-4184 | |
Matthew Joseph Mcconnell, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 333 Cedar St, Ynhh Internal Medicine-gi,section Of Digestive Diseases, New Haven, CT 06510 Phone: 203-785-7012 | |
Marie Anjeliese Rodriguez, Nephrology Medicare: Medicare Enrolled Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 | |
Dr. Margaret M Xu, MD Nephrology Medicare: Medicare Enrolled Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 | |
Carola Marte, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1450 Chapel St, Haelen Center, New Haven, CT 06511 Phone: 203-789-4135 Fax: 203-867-5241 | |
Jeanette M Tetrault, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Long Wharf Dr, New Haven, CT 06511 Phone: 203-781-4600 Fax: 203-781-4624 |